Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
First-in-elephant, proof-of-concept vaccination study Study design Study elephants Equivalent to phase I vaccine trial standards, healthy adult elephants rather than EEHV-susceptible calves were chosen for this first-in-elephant proof-of-concept study
Some clients benefit from weekly infusions, while others see improvements with monthly treatments
Its scientific value lies in helping researchers explore cytoprotection, cell migration, and tissue-repair-associated mechanisms under controlled experimental conditions
Reviews & Ratings There have been no reviews for this product yet
US$ 22.93
US$ 25.22
US$ 21.78
US$ 23.18
